Major funding opportunity opens for early cancer diagnostics

September 4, 2026
Innovate UK, NHS, Scotland, cancer research funding

Up to £25.4m in funding is available for collaborative projects developing technologies to improve the early detection and diagnosis of …

Androlabs receives UK authorisation for new Testavan presentation

September 4, 2026
Androlabs, Testavan, UK authorisation, hypogonadism, testosterone

Androlabs has received UK marketing authorisation for a new presentation of Testavan 4.6 mg/actuation transdermal gel for testosterone replacement therapy …

CEPI backs African-led Bundibugyo Ebola vaccine development

September 3, 2026
Africa, CEPI, Ebola vaccine

Minapharm Group is to receive up to US$16.5m from the Coalition for Epidemic Preparedness Innovations (CEPI) to advance development of …

Cytomos appoints life sciences executive to board

September 2, 2026
Alex Jones, Cytomos, non-executive director

Edinburgh-based biotechnology company Cytomos has appointed life sciences executive Dr Alex Jones as a non-executive director as it moves to …

Cell therapy partnership aims to bring liver disease treatment closer to US patients

September 1, 2026
Resolution Therapeutics, US, cell therapy, liver disease

Resolution Therapeutics has partnered with the Blood Centers of America (BCA) to support community-based delivery of its experimental cell therapy …

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026
NHS, Scottish healthcare, hearing loss, neonatal innovations

Scottish healthcare teams are introducing a range of innovations aimed at improving outcomes for newborns, including a rapid genetic test …

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026
De Novo, FDA, light-filtering device, migraine

The US Food and Drug Administration (FDA) has granted De Novo marketing authorisation to Avulux, a precision optical filter designed …

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026
Southgate Global, UK Innovation Lab, fulfilment and manufacturing operations, logistics

Southgate Global has opened its first UK Innovation Lab, creating an in-house facility for developing and testing equipment and practical …

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026
AI, Bioptimus, Cancer Research Horizons, Cancer Research UK, colorectal cancer

Bioptimus has partnered with Cancer Research Horizons, the innovation arm of Cancer Research UK, to give the AI biotechnology company …

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026
Agentis Health Group, CQC, Clinical Pharmacist Solutions, NHS

Agentis Health Group has acquired Clinical Pharmacist Solutions (CPS), strengthening its pharmacy and digital health business as the NHS expands …

Made Smarter expands North West team as demand for digital support grows

August 25, 2026
Made Smarter, North West team

Made Smarter has appointed four specialists to its North West team as increasing numbers of SME manufacturers seek support with …

Long-acting therapies set to reshape HIV treatment market

August 21, 2026
26th International AIDS Conference, HIV, long-acting therapies

The HIV treatment market is increasingly being shaped by therapies designed to reduce medication burden and improve convenience, with long-acting …

MHRA authorises Lynkuet for hot flushes linked to breast cancer therapy

August 21, 2026
MHRA, breast cancer therapy, hot flushes

The Medicines and Healthcare products Regulatory Agency (MHRA) has authorised an extension to the indication for Lynkuet (elinzanetant), allowing its …

MHRA approves Romvimza for tenosynovial giant cell tumour

August 20, 2026
MHRA, Romvimza, tenosynovial giant cell tumour

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Romvimza (vimseltinib) for adults with tenosynovial giant cell tumour (TGCT) …

NICE recommends allergy immunotherapy tablets for younger children

August 19, 2026
NICE, allergy immunotherapy tablets, severe allergic rhinitis, younger children

NICE has recommended two sublingual immunotherapy tablets for children with moderate to severe allergic rhinitis whose symptoms are not adequately …

Dunbar Pharmaceuticals and IPS Pharma announce distribution agreement

August 18, 2026
Dunbar Pharmaceuticals, IPS Pharma, Ireland; UK

Irish pharmaceutical manufacturer Dunbar Pharmaceuticals has made its plant-derived dronabinol active pharmaceutical ingredient (API), WaterClear THC, available in the UK …

Panthera opens clinical trial site at Keele University

August 17, 2026
Keele University, Panthera, clinical trial site

Panthera has opened a clinical trial clinic at Keele University, expanding its research network to 11 sites across the UK …

Santen joins inaugural Global Summit for Eye Health as partner

August 14, 2026
Global Summit for Eye Health, Santen, world health organization

Santen Pharmaceutical has become a High Impact Partner for the inaugural Global Summit for Eye Health, joining governments, international organisations …

EHP Awards 2027 open for entries following outstanding inaugural year

August 13, 2026
EHP Awards

The Awards are a leading celebration of excellence in healthcare partnership working Entries are now open for the EHP Awards …

NHS spends £240m storing patient records as digital reforms gather pace

August 13, 2026
NHS, Single Patient Record, The King's Fund, digital reform

The NHS spent almost £240m storing patient records in 2024/25, according to analysis by The King’s Fund, highlighting the continued …

NHS awards national diabetes education contract to Leicester programme

August 12, 2026
NHS, University Hospitals of Leicester NHS Trust, diabetes education

University Hospitals of Leicester NHS Trust (UHL) has been awarded a five-year contract to deliver NHS England’s Healthy Living service, …

The Gateway to Local Adoption Series

Latest content